Strata Critical Medical (SRTA) Change in Acquisitions & Divestments (2023 - 2026)

Strata Critical Medical (SRTA) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $30.5 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $30.5 million, down 71.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 241.46% YoY), and the FY2025 annual result was $70.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments improved to $30.5 million in Q1 2026 per SRTA's latest filing, from -$132.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $131.2 million in Q1 2023 and troughed at -$168.0 million in Q4 2024.
• A 4-year average of $12.1 million and a median of $47.6 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments increased 20.91% in 2025, then slumped 71.69% in 2026.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at -$110.7 million in 2023, then tumbled by 51.78% to -$168.0 million in 2024, then advanced by 20.91% to -$132.8 million in 2025, then soared by 122.96% to $30.5 million in 2026.
• Business Quant data shows SRTA's Change in Acquisitions & Divestments at $30.5 million in Q1 2026, -$132.8 million in Q4 2025, and $51.7 million in Q3 2025.